Methods of treating conditions associated with corneal transplantation
AssigneeXoma Corporation
InventorPatrick J. Scannon
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of treating a subject suffering from adverse effects, complications or conditions, associated with or resulting from corneal transplantation, by topical administration of suitable ophthalmic preparations of bactericidal/permeability-increasing (BPI) protein products.
Claims9
A method of treating a corneal transplant patient comprising topically administering to the cornea of the patient an amount of a bactericidal/permeability-increasing (BPI) protein product effective to reduce the incidence of transplant rejection or of corneal neovascularization or of corneal opacification.
A method for reducing the incidence of corneal transplant rejection or of corneal neovascularization or of corneal opacification comprising application of an effective amount of a BPI protein product to corneal graft tissue prior to transplantation.
Dependencies are inferred from the claim text.